期刊文献+

厄贝沙坦联合氨氯地平治疗社区高血压的疗效与依从性研究

Research on Curative Effect and Compliance of Irbesartan and Amlodipine in Treatment of Community Hypertension
下载PDF
导出
摘要 目的研究社区高血压患者应用厄贝沙坦联合氨氯地平治疗的效果和依从性。方法选取2015年1—12月期间,向阳镇卫生院接受治疗和管理的高血压患者110例,按随机数字表法分为观察组与对照组,每组55例。观察组予以厄贝沙坦和氨氯地平口服治疗,而对照组单纯予以厄贝沙坦口服治疗,对比2组治疗12周后的效果与依从性。结果观察组的治疗总有效率为94.55%,显著高于对照组的83.64%(P<0.05);治疗后2组的24 h SBP、24 h DBP、d SBP、d DBP、n SBP及n DBP水平均明显降低,而观察组明显低于对照组(P<0.05);治疗第8、12周,观察组的依从性明显高于对照组(P<0.05)。结论厄贝沙坦与氨氯地平联合治疗社区高血压疗效确切,能够提高降压效果、降低血压波动幅度并提高患者的治疗依从性,值得推广应用。 Objective To research the curative effect and compliance of irbesartan and amlodipine in treatment of commu-nity hypertension. Methods 110 cases of patients with hypertension receiving treatment and management in the Xiangyang health center from January 2015 to December 2015 were selected and randomly divided into two groups with 55 cases in each, the observation group took irbesartan and amlodipine orally, while the control group simply took irbesartan orally, and the effect in 12 weeks after treatment and compliance of the two groups were compared. Results The total treatment effec-tive rate in the observation group was obviously higher than that in the control group, (94.55% vs 83.64%), (P〈0.05), the 24hSBP, 24h DBP, dSBP, dDBP, nSBP and nDBP levels of the two groups obviously decreased after treatment, but the 24hSBP, 24h DBP, dSBP, dDBP, nSBP and nDBP in the observation group were obviously lower than those in the control group, (P〈0.05), and the compliance in the observation group at 8-week and 12-week after treatment were obviously high-er than that in the control group, (P〈0.05). Conclusion The curative effect of irbesartan and amlodipine in treatment of community hypertension is definite, which can improve the antihypertensive effect, reduce the fluctuation range of blood pressure and improve the treatment compliance of patients, and it is worth promotion and application.
作者 王炳福
出处 《中国卫生产业》 2016年第14期31-33,共3页 China Health Industry
关键词 社区高血压 氨氯地平 厄贝沙坦 依从性 临床疗效 Community hypertension Amlodipine Irbesartan Compliance Clinical curative effect
  • 相关文献

参考文献11

二级参考文献80

  • 1赵玉娟.蒙诺合用辛伐他汀治疗高血压的疗效观察[J].锦州医学院学报,2005,26(4):80-81. 被引量:4
  • 2吴宪红,姚晓伟,吴贵福.老年高血压病患者血压控制不良的相关原因与对策[J].中国动脉硬化杂志,2007,15(1):5-5. 被引量:13
  • 3刘国仗,胡大一,陶萍,等.心血管药物临床试验评价方法的建议[J].中华心血管杂志,2006,16(1):56-62.
  • 4张鲁英,隋向梅.智能反馈型音乐放松系统治疗老年高血压伴抑郁焦虑情绪32例分析[J].医药前沿,2012,2(2):218.
  • 5Kaneda R, Kario K, Hoshide S, et al. Morning blood pressure hyper-reactity is an independent predictor for hypertensive cardiac hyperthrophy in a community-dwelling population. Am J Hypertens, 2005, 18:1528-1533.
  • 6Lewington S, Clarke R, Qizilbash N, et al. Age-specific rele vance of usual blood pressure to vascular mortality: a meta-a nalysis of individual data for one million adults in 61 prospective studies. Lancet, 2002, 360:1903-1913.
  • 7Vasovic O, Zamaklar M, Lalic K, et al. The prevalence of hypertension and microalbuminuria in diabetes mellitus type 1 and type 2. Srp Arh Celok Lek, 2005, 133:229-232.
  • 8Greathouse MK, Weir MR. The role of ARBs alone or with HCTZ in the treatment of hypertension and prevention of cardiovascular and re- nal complications[ J]. Postgrad Med, 2012 ; 124:40 - 52.
  • 9Sonoda M, Aoyagi T, Takenaka K, et al. A one - year study of the antiatherosclerotic effect of the angiotensin - II receptor blocker losar- tan in hypertensive patients. A comparison with angiotension - con- vetting enzyme inhibitors[ J]. Int Heart J, 2008 ; 49:95 - 103.
  • 10Coyle D, Rodby R, Soroka S, et al. Cost - effectiveness of irbrsartan 300 mg given early versus late in patients with hypertension and a history of type 2 diabeetes and renal disease: a Canadian perspective [J]. Clin Ther, 2007; 29:1508-1523.

共引文献221

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部